74938-11-7,
7-Hydroxy-DPAT hydrobromide,
7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol hydrobromide,
76135-30-3,
(+/-)-7-OH-DPAT,
159795-63-8,
CHEMBL1255966,
R(+)-7-Hydroxy-DPAT hydrobromide,
MFCD00153809,
(+/-)-7-Hydroxy-DPAT hydrobromide,
(+/-)-7-HYDROXY-2-DIPROPYLAMINOTETRALIN HYDROBROMIDE,
(+/-)-7-Hydroxy-2-(di-n-propylamino)tetralin hydrobromide,
2-Naphthalenol, 7-(dipropylamino)-5,6,7,8-tetrahydro-, hydrobromide,
SR-01000075408,
7-OH-dpat hydrobromide,
82730-72-1,
C16H26BrNO,
MLS002153292,
DPAT, 7-OH-,
SCHEMBL4204027,
CTK2G8173,
R(+)-7-Hydroxy(dipropylamino)tetralin hydrobromide,
(y)-7-Hydroxy-DPAT hydrobromide,
(+/-)-7-OH-DPAT hydrobromide,
(?)-7-Hydroxy-DPAT hydrobromide,
Tox21_500616,
1654AC,
BN0038,
AKOS016008929,
CCG-221920,
LP00616,
NCGC00093990-01,
NCGC00261301-01,
R(+)-2-Dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide,
SMR001230715,
NCG-C00093990-01,
AX8043268,
DB-017869,
EU-0100616,
FT-0655074,
H 8653,
(+/-)-7-HYDROXY-2-DIPROPYL-AMINOTETRALIN,
R(+)-7-Hydroxy-DPAT hydrobromide, >98%, solid,
7-hydroxy-2-(di-n-propylamino)tetralin hydrobromide,
SR-01000075408-1,
SR-01000075408-3,
( inverted exclamation markA)-7-OH-DPAT hydrobromide,
( inverted question mark)-7-Hydroxy-DPAT hydrobromide,
(+/-)-7-Hydroxy-2-di-n-propylaminotetralin hydrobromide,
( inverted exclamation markA)-7-Hydroxy-DPAT hydrobromide,
7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol hydrobromide,
(+/-)-2-Dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide,
( inverted exclamation markA)-2- paragraph signthorn+/-u degrees +/->>u-7-oC>>u-1,2,3,4-EACaYA CaaaEaNI,
( inverted question mark)-7-OH-DPAT HBr; ( inverted question mark)-Hydroxy-dipropylaminotetralin hydrobromide,
7-Ohdpat,
UNII-RR7D75YDF4,
DP-7-AT,
7-hydroxy-dipropyl-aminotetralin,
C16-H25-N-O,
7-Hydroxy-2-N,N-dipropylaminotetralin,
CID11957566,
7-Hydroxy-N,N-di-n-propyl-2-aminotetralin,
N,N-Di-n-propyl-7-hydroxy-2-aminotetralin,
EU-0100569,
7-(Dipropylamino)-5,6,7,8-tetrahydro-2-naphthalenol,